ADIM
FRO icon

Alpha DNA Investment Management’s Frontline FRO Stock Holding History

Alpha DNA Investment Management’s Portfolio FRO Stock Details FRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-111,550
Closed -$987K – 170
2022
Q2 		$987K Buy
+111,550
New +$1.01M 0.84% 64
2021
Q1 		– Sell
-758
Closed -$4K – 722
2020
Q4 		$4K Buy
+758
New +$4.87K ﹤0.01% 394

Other funds holding FRO

F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpha DNA Investment Management's FRO Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of Frontline (FRO) in Q3 2022, closing a stake of 111,550 shares — an estimated $987K sold.

Alpha DNA Investment Management first reported a position in FRO in Q4 2020 and held it in 2 quarters. The position peaked at $987K in Q2 2022. 160 funds tracked by Wall St. Rank hold FRO as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining Frontline position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 111,550 Frontline shares in Q3 2022, an estimated $987K.
  • Alpha DNA Investment Management first reported a position in Frontline in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Frontline position peaked at $987K in Q2 2022.
  • 160 funds tracked by Wall St. Rank held Frontline as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.